Status:
UNKNOWN
OPV as Potential Protection Against COVID-19
Lead Sponsor:
Bandim Health Project
Conditions:
Poliovirus Vaccine, Oral
COVID
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Since the 1960s, studies have shown that oral polio vaccine (OPV) may have beneficial non-specific effects, reducing morbidity and mortality from other infections than polio. Such beneficial non-speci...
Eligibility Criteria
Inclusion
- Living in a household which has had a census visit conducted after 1 January in 2017. Age above 50.
Exclusion
- Previous adverse events to OPV; Previous documented COVID-19; Acute severe infection.
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
3400 Patients enrolled
Trial Details
Trial ID
NCT04445428
Start Date
July 15 2020
End Date
May 1 2022
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Guinea-Bissau